The global safety syringes market, valued at approximately USD 7.1 billion in 2022, is projected to grow at a steady compound annual growth rate (CAGR) of over 4.5% during the forecast period from ...

Faced with soaring prices and limited access to obesity medications, a growing number of Americans are taking matters into ...

Novo Nordisk has launched Wegovy in India, a weight-loss drug challenging Eli Lilly's Mounjaro. Available by June 2025, ...

Biocon Biologics secures Health Canada approval for Yesafili, the first biosimilar to Eylea® in Canada, with a global launch ...

Type 2 diabetes (T2D) results from the cells’ insulin resistance, and to date, insulin therapy and diabetes medications targeting glycemic management have failed to reverse the increase in T2D ...

Kolkata: Endocrinology professor at SSKM Sujoy Ghosh's innovative model for detection and treatment of paediatric diabetes in ...

An expert committee that advises the Centers for Disease Control and Prevention on vaccines is meeting for the first time since Health Secretary Robert F. Kennedy Jr. abruptly replaced the committee's ...

In the insulin pen group, 12 patients (35%) continued to use insulin pens, 14 patients (41%) switched back to vials and syringes, 2 patients (6%) used both insulin vials and pens, and 6 patients ...

Patients receiving insulin with a vial and syringe who converted to pen therapy were compared with those who continued to use the vial and syringe method in both unmatched comparisons (n = 560 and ...

The global Insulin Delivery Device Market, valued at US$32.6 billion in 2024 stood at US$35.3 billion in 2025 and is ...

Wegovy is being made available in five dosing strengths with an easy-to-use pen device, which does away the use of syringes ...